Table 2.

Proportion of sample prescribed ACE inhibitor by albuminuria category and hypertension diagnosis

Albuminuria categories (mg/g)	Patients without hypertension	Patients with hypertension
<30 (A1)	5% (3/57)	62% (23/37)*
30–300 (A2)	17% (4/23)*	53% (8/15)*
>300 (A3)	0% (0/3)*	100% (9/9)*
Total	8% (7/83)	66% (40/61)

Kidney Disease: Improving Global Outcomes designations are as follows: A1, normal to mildly increased albuminuria; A2, moderately increased albuminuria; A3, severely increased albuminuria.

*ACE inhibitor was assumed to be indicated for the treatment of hypertension and/or elevated microalbuminuria.